A recombinant analgesic-antitumor peptide (rAGAP), a polypeptide, led to the inhibition of migration via MMP-9 inactivation in SHG44 cells (human malignant glioma cells) (Zhao et al., 2011). This evidence concerns the gene MMP9 and malignant glioma.